Helix Return On Tangible Assets from 2010 to 2024
| HBP Stock | CAD 0.22 0.01 4.76% |
Return On Tangible Assets | First Reported 2010-12-31 | Previous Quarter (7.03) | Current Value (6.68) | Quarterly Volatility 2.80032718 |
Check Helix BioPharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helix main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.5 K, Interest Expense of 12 K or Selling General Administrative of 893.5 K, as well as many exotic indicators such as Price To Sales Ratio of 20.62, Dividend Yield of 0.0 or Days Sales Outstanding of 74.71. Helix financial statements analysis is a perfect complement when working with Helix BioPharma Valuation or Volatility modules.
Helix | Return On Tangible Assets |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Helix BioPharma Correlation against competitors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Helix Stock analysis
When running Helix BioPharma's price analysis, check to measure Helix BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helix BioPharma is operating at the current time. Most of Helix BioPharma's value examination focuses on studying past and present price action to predict the probability of Helix BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helix BioPharma's price. Additionally, you may evaluate how the addition of Helix BioPharma to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |